Cronos Group Inc. logo

CRONCronos Group Inc.

CRON Stock Price, Valuation & Chart | Cronos Group Inc.

Compare

CRON Historical price chart

CRON Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.21B
PE Ratio30.77
EPS0.11
Trading Volume844.65K
Today's High/Low3.4/3.23
Dividend Yield0.00
52 Week High/Low3.61/2.28
Shares Outstanding373.66M
CRON Financial Statement
CRON Analyst ratings
CRON Analysis & performance metrics

CRON Company profile

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and…

CRON Management team

Management
Adam Wagner
Senior Vice President & Head of Cronos Israel
James Holm
Executive Officer
James Andrew McGinness III
Vice President, Controller & Principal Accounting Officer
Michael Ryan Gorenstein J.D.CEO
President, Chief Executive Officer & Chairman
Anna ShlimakCFO
Chief Financial Officer
Arye Weigensberg
Senior Vice President and Head of Research & Development
Jeffrey David Jacobson
Chief Growth Officer
Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
Total 8 executives

CRON Frequently asked questions

What is Cronos Group Inc. (CRON) Stock Price?

Current stock price of Cronos Group Inc. (CRON) stock is $3.240. The stock price is -4.14% lower in the session. The intraday range can be seen from this page. Volume of Cronos Group Inc. (CRON) stock is 844.65K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Cronos Group Inc. (CRON) stock price going up or down today?

The stock price of Cronos Group Inc. (CRON) can change with earnings, company news, and overall market sentiment. Cronos Group Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cronos Group Inc. stock expensive at its current price?

Whether Cronos Group Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRON on this page is 30.77. EPS on this page is 0.11. Compare those figures with peers and growth expectations before deciding if the current Cronos Group Inc. price is justified.

How has the stock price of Cronos Group Inc. (CRON) performed historically?

Historical performance for Cronos Group Inc. (CRON) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRON reacted to past earnings and market events.

Should I buy Cronos Group Inc. (CRON) stock, at this price?

Buying Cronos Group Inc. (CRON) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.